Albert Ribickas
Manager, Bloody & Marrow Transplant Laboratory, Clinical Trial & Commercial Product Handling Team Moffitt Cancer Center
Al Ribickas is the BMT Laboratory Operations Manager in the Cell Therapy and Gene Engineering Facility at the Moffitt Cancer in Tampa Florida. Al has provided leadership for cellular therapy facilities for over 24 years. He attended the University of South Florida receiving a degree in Clinical Laboratory Sciences. He is board certified by the American Society of Clinical Pathology as a Medical Technologist, a Specialist in Blood Banking, and as a Hemapheresis Practioner. He has been at the Moffitt Cancer Center since it’s opening in 1987. He initially worked as a blood bank technologist in the transfusion service until 2001. During his time in the transfusion service, he was trained in extracorporeal photopheresis for the treatment of Sezary syndrome, and for the treatment of graft versus host disease. This inspired him to explore, and move to the apheresis collection and processing laboratories of the blood and marrow transplant program to enhance his skills, and contribute to the emerging area of cell therapies. Al has worked on the production of various cellular therapies clinical trial products, and the implementation of commercial FDA approved products.
Seminars
- Navigating last mile logistics to support coordination between providers, couriers, and healthcare providers and ensure timely therapy delivery
- Optimizing packaging, labelling, and cold-chain procedures to enhance efficiency, maintain safety, and ensure regulatory compliance
- Engaging regulators, CROs, CDMOs, and logistics partners to align expectations, reduce delays, and strengthen end-toend connectivity
- Managing operational complexity in a mixed ecosystem of bags and vials to maintain workflow, optimize storage, and manage inventory adjustments
- Utilizing equipment and materials for scale-up to ensure each stage of cell culture and therapy differentiation is reliably supported
- Mitigating risks during technology or material transitions to protect product integrity, prevent contamination, and maintain regulatory compliance